Evidence map›Paper›PMID 26392561›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Dialogue between E. coli free radical pathways and the mitochondria of C. elegans.

J Amaranath Govindan, Elamparithi Jayamani, Xinrui Zhang, Eleftherios Mylonakis, Gary Ruvkun

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 40 citations in OpenAlex.

  1. Environmental science. Processes & impacts · 2026
    Article
  2. Article
  3. Use ofBiomolecules · 2024
    Review
  4. ReducedAntioxidants (Basel, Switzerland) · 2023
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Xenobiotic metabolism and transport inJournal of toxicology and environmental health. Part B, Critical reviews · 2021
    Review
  11. Caenorhabditis elegans: a model to understand host-microbe interactions.Cellular and molecular life sciences : CMLS · 2020
    Review
  12. ROS-based lethality ofProceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

J Amaranath GovindanDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114; Department of Genetics, Harvard Medical School, Boston, MA 02115;
Elamparithi JayamaniDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114; Division of Infectious Diseases, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI 02903.
Xinrui ZhangDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114;
Eleftherios MylonakisDivision of Infectious Diseases, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI 02903.
Gary RuvkunDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114; Department of Genetics, Harvard Medical School, Boston, MA 02115; ruvkun@molbio.mgh.harvard.edu.
Massachusetts General Hospital · USBrown University · USHarvard University · US

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
Inositol signaling in C. elegans Senescence and DiapauseR01AG043184 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI RUVKUN, GARY B · 2012 to 2021
$4.9M
NIA NIH HHS AG043184-16ANIA NIH HHS R01 AG043184NIH HHS P40 OD010440
6 · The paper itself

Abstract

The microbial world presents a complex palette of opportunities and dangers to animals, which have developed surveillance and response strategies to hints of microbial intent. We show here that the mitochondrial homeostatic response pathway of the nematode Caenorhabditis elegans responds to Escherichia coli mutations that activate free radical detoxification pathways. Activation of C. elegans mitochondrial responses could be suppressed by additional mutations in E. coli, suggesting that C. elegans responds to products of E. coli to anticipate challenges to its mitochondrion. Out of 50 C. elegans gene inactivations known to mediate mitochondrial defense, we found that 7 genes were required for C. elegans response to a free radical producing E. coli mutant, including the bZip transcription factor atfs-1 (activating transcription factor associated with stress). An atfs-1 loss-of-function mutant was partially resistant to the effects of free radical-producing E. coli mutant, but a constitutively active atfs-1 mutant growing on wild-type E. coli inappropriately activated the pattern of mitochondrial responses normally induced by an E. coli free radical pathway mutant. Carbonylated proteins from free radical-producing E. coli mutant may directly activate the ATFS-1/bZIP transcription factor to induce mitochondrial stress response: feeding C. elegans with H2O2-treated E. coli induces the mitochondrial unfolded protein response, and inhibition of a gut peptide transporter partially suppressed C. elegans response to free radical damaged E. coli.

Indexed as

AnimalsAnimals, Genetically ModifiedBiosynthetic PathwaysCaenorhabditis elegansCaenorhabditis elegans ProteinsEscherichia coliFree RadicalsGene ExpressionHost-Pathogen InteractionsMicroscopy, FluorescenceMitochondriaMutationReverse Transcriptase Polymerase Chain ReactionTranscription FactorsATFS-1 protein, C elegansCaenorhabditis elegans ProteinsFree RadicalsTranscription FactorsC. eleganshost–microbe dialoguemitochondria

Identifiers

PMID26392561
PMCPMC4603447
OpenAlexW2202241795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.